Collaboration - August 17, 2022
Genmab and BioNTech expand global strategic collaboration
The two companies have announced an expansion of their collaboration to develop and commercialize novel immunotherapies for the treatment of cancer patients. Under the expansion, Genmab and BioNTech will jointly work to research, develop, and commercialize novel monospecific antibody candidates for various cancer indications. Since 2015, the companies have been working on the joint development […]
COVID-19 - August 2, 2021
Pfizer-BioNTech’s second dose triggers powerful immune response
A new study has revealed that the second dose of the Pfizer-BioNTech COVID-19 vaccine triggers massive immune response against the virus. Researchers at the Stanford University School of Medicine, US, have investigated the effect of the second Pfizer-BioNTech COVID-19 vaccine dose in the human body. The study, published in Nature, was designed to find out […]
COVID-19 - April 19, 2021
Pfizer/BioNTech to supply the EU with 100 million additional vaccine doses
Pfizer and BioNTech have announced they will supply an additional 100 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s (EC) decision to exercise its option to purchase an additional 100 million doses under its expanded Advanced […]
COVID-19 - March 1, 2021
Pfizer and BioNTech to evaluate COVID-19 booster and new vaccine variants
Pfizer and BioNTech have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on immunity against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants. The study will draw upon participants from the Phase 1 study in […]
COVID-19 - January 12, 2021
New in vitro study results about Pfizer/BioNTech’s COVID-19 vaccine
Pfizer and BioNTech have announced results from an in vitro study that shows the antibodies from people who have received their vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains. The results were published on the preprint server bioRxiv. Variants of SARS-CoV-2 Rapidly spreading variants of SARS-CoV-2 […]
COVID-19 - January 10, 2021
Production and supply – A logistics challenge
The manufacturing, packaging and transportation of COVID-19 vaccines requires a smooth, effective and safe supply chain. Time is of the essence, and the pharma industry supply chain is facing big logistics challenges. In record time the global life science industry has been able to discover and develop one vaccine approved for full use, six vaccines […]
